title: Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.
abstract: The outcomes in adult B-cell acute lymphoblastic leukemia (ALL) remain inferior to those achieved in pediatric populations. Targeted therapy with monoclonal antibodies may improve outcomes in adult B-cell ALL without significant additive toxicity. Rituximab is the best known monoclonal antibody and is routinely used in combination chemo-immunotherapy for treatment of adult B-cell ALL and Burkitts leukemia. A number of other monoclonal antibodies are currently under investigation for treatment of adult B-cell ALL including unconjugated antibodies (eg., ofatumumab, alemtuzumab and epratuzumab), antibodies conjugated to cytotoxic agents (eg., inotuzumab ozogamycin and SAR3419), antibodies conjugated to toxins such Pseudomonas or Diptheria toxins (eg., BL22 and moxetumomab pasudotox), and T-cell engaging bi-specific antibodies that redirect cytotoxic T lymphocytes to lyse target ALL cells (eg., blinatumomab). In this article we review the therapeutic implications, current status and results of monoclonal antibody-based therapy in adult B-cell ALL.
authors.affiliation: Department of Leukemia, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0428, Houston, TX 77030, USA.
authors.forename: Naval
authors.initials: N
authors.lastname: Daver
authors.forename: Susan
authors.initials: S
authors.lastname: O'Brien
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007155:Immunologic Factors
references.citation: Clin Cancer Res. 2009 Jun 15;15(12):4038-45
references.pmid: 19509168
references.citation: Leuk Lymphoma. 2011 Feb;52(2):325-7
references.pmid: 21077738
references.citation: J Clin Oncol. 2010 Jul 20;28(21):3525-30
references.pmid: 20458041
references.citation: Leukemia. 2005 Jan;19(1):49-56
references.pmid: 15538405
references.citation: J Clin Oncol. 2010 Aug 20;28(24):3880-9
references.pmid: 20660823
references.citation: Lancet. 2010 Oct 2;376(9747):1164-74
references.pmid: 20888994
references.citation: Cancer. 2008 Oct 15;113(8):2097-101
references.pmid: 18720356
references.citation: J Biol Chem. 1995 Mar 17;270(11):6088-99
references.pmid: 7890742
references.citation: J Clin Oncol. 2003 Aug 15;21(16):3051-9
references.pmid: 12837807
references.citation: Cancer. 2010 Mar 1;116(5):1165-76
references.pmid: 20101737
references.citation: Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3982S-90S
references.pmid: 14506197
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6448-58
references.pmid: 22003072
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6417-27
references.pmid: 22003069
references.citation: J Clin Oncol. 2011 Feb 10;29(5):532-43
references.pmid: 21220592
references.citation: Expert Opin Investig Drugs. 2011 Jan;20(1):75-85
references.pmid: 21142808
references.citation: Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5742-7
references.pmid: 21436054
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1749-55
references.pmid: 20194866
references.citation: N Engl J Med. 1998 Aug 27;339(9):605-15
references.pmid: 9718381
references.citation: N Engl J Med. 2001 Jul 26;345(4):241-7
references.pmid: 11474661
references.citation: Leukemia. 2011 Jan;25(1):181-4
references.pmid: 20944674
references.citation: J Clin Oncol. 2009 Feb 20;27(6):911-8
references.pmid: 19124805
references.citation: Immunology. 1998 Nov;95(3):427-36
references.pmid: 9824507
references.citation: Leuk Lymphoma. 2011 Jun;52(6):1098-107
references.pmid: 21348573
references.citation: Pediatr Blood Cancer. 2015 Jul;62(7):1171-5
references.pmid: 25732247
references.citation: Cancer Res. 2011 Oct 15;71(20):6300-9
references.pmid: 21998010
references.citation: Blood. 2009 Dec 3;114(24):5007-15
references.pmid: 19828699
references.citation: Ann Hematol. 2004 Apr;83(4):201-5
references.pmid: 14648023
references.citation: Leukemia. 2000 Dec;14(12):2223-33
references.pmid: 11187913
references.citation: Clin Cancer Res. 2010 Mar 15;16(6):1894-903
references.pmid: 20215554
references.citation: J Immunol. 2006 Jul 1;177(1):362-71
references.pmid: 16785532
references.citation: Blood. 2002 May 15;99(10):3554-61
references.pmid: 11986207
references.citation: J Clin Oncol. 2011 Feb 10;29(5):551-65
references.pmid: 21220611
references.citation: Best Pract Res Clin Haematol. 2006;19(4):701-13
references.pmid: 16997178
references.citation: Science. 2008 Aug 15;321(5891):974-7
references.pmid: 18703743
references.citation: Blood. 2002 Feb 1;99(3):863-71
references.pmid: 11806988
references.citation: Br J Haematol. 2009 Jun;146(1):76-85
references.pmid: 19438471
references.citation: Blood. 2008 Nov 15;112(10):3982-8
references.pmid: 18780832
references.citation: Br J Haematol. 1986 Nov;64(3):479-86
references.pmid: 3539172
references.citation: Clin Cancer Res. 2002 Apr;8(4):995-1002
references.pmid: 11948105
references.citation: Lancet. 2011 Jan 1;377(9759):42-51
references.pmid: 21176949
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1756-65
references.pmid: 20194844
references.citation: N Engl J Med. 2002 Jan 24;346(4):235-42
references.pmid: 11807147
references.citation: J Clin Oncol. 2012 Nov 1;30(31):3876-83
references.pmid: 22891271
references.citation: Blood. 1989 May 1;73(6):1431-9
references.pmid: 2713487
references.citation: J Natl Cancer Inst. 2011 Dec 7;103(23):1799-806
references.pmid: 22021664
references.citation: N Engl J Med. 2006 Jan 12;354(2):166-78
references.pmid: 16407512
references.citation: Blood. 2005 Dec 1;106(12):3760-7
references.pmid: 16105981
references.citation: Mol Immunol. 2007 Feb;44(6):1331-41
references.pmid: 16814387
references.citation: Lancet. 2008 Mar 22;371(9617):1030-43
references.pmid: 18358930
references.citation: Blood. 2009 Apr 16;113(16):3792-800
references.pmid: 18988862
references.citation: J Clin Oncol. 2009 Jun 20;27(18):2983-90
references.pmid: 19414673
references.citation: J Clin Oncol. 2005 Oct 1;23(28):7161-7
references.pmid: 16192600
references.citation: Blood. 1993 Aug 1;82(3):807-12
references.pmid: 7687895
references.citation: Anticancer Drugs. 2001 Jun;12 Suppl 2:S1-4
references.pmid: 11508930
references.citation: J Clin Oncol. 2000 Feb;18(3):547-61
references.pmid: 10653870
references.citation: Blood Rev. 2012 Jan;26(1):25-32
references.pmid: 21958552
references.citation: Ann Hematol. 2004;83 Suppl 1:S127-8
references.pmid: 15124704
references.citation: Cancer. 2006 Jun 15;106(12):2645-51
references.pmid: 16688777
references.citation: Leuk Lymphoma. 2007 Dec;48(12):2424-36
references.pmid: 18067019
references.citation: Blood. 2004 Sep 15;104(6):1793-800
references.pmid: 15172969
references.citation: J Clin Pathol. 1998 May;51(5):364-9
references.pmid: 9708202
references.citation: Hematol Oncol Clin North Am. 2000 Dec;14(6):1307-25, ix
references.pmid: 11147225
references.citation: Pediatr Blood Cancer. 2009 Dec;53(6):978-83
references.pmid: 19637330
references.citation: Blood. 2009 Jun 18;113(25):6330-7
references.pmid: 18703706
references.citation: J Clin Oncol. 2005 Sep 20;23(27):6719-29
references.pmid: 16061911
references.citation: Haematologica. 2010 Feb;95(2):324-8
references.pmid: 19773266
references.citation: Cancer. 2006 Apr 1;106(7):1569-80
references.pmid: 16502413
references.citation: CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
references.pmid: 16514137
references.citation: Blood. 2004 Nov 15;104(10):3028-37
references.pmid: 15256423
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6398-405
references.pmid: 22003067
references.citation: J Clin Oncol. 2008 Aug 1;26(22):3756-62
references.pmid: 18669463
references.citation: N Engl J Med. 2000 Apr 6;342(14):998-1006
references.pmid: 10749961
references.citation: Lancet Oncol. 2012 Apr;13(4):403-11
references.pmid: 22357140
references.citation: Hematol Oncol Clin North Am. 2009 Oct;23(5):949-71, v
references.pmid: 19825447
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2085-93
references.pmid: 20308665
references.citation: Cancer. 2004 Dec 15;101(12):2788-801
references.pmid: 15481055
references.citation: J Clin Oncol. 2007 Dec 10;25(35):5616-23
references.pmid: 17984186
references.citation: Blood. 2009 Feb 12;113(7):1408-11
references.pmid: 18974371
references.citation: Cancer Res. 2007 Feb 1;67(3):1270-81
references.pmid: 17283164
references.citation: Cytometry B Clin Cytom. 2010 May;78(3):147-53
references.pmid: 20201055